KyooBe Tech is an emerging engineering company focusing on the development of innovative manufacturing platforms, that drives the pharmaceutical production of tomorrow. With an interdisciplinary team of motivated engineers and biotechnologists, we develop high-quality technological solutions for biological challenges in vaccines and cell and gene therapy. Our vision is to enable access of next-generation therapeutic methods to a broader patient population.

Four Fraunhofer institutes lead the scientific forefront of this technology, continuously innovating and exploring new applications of LEEI-technologies. They conduct extensive pathogen studies to identify potential vaccine candidates, while also spearheading the development of the prototype system.